Literature DB >> 6292429

Detection of antibodies in human serum against the fimbrial haemagglutinin of Bordetella pertussis by enzyme-linked immunosorbent assay.

M Granström, A A Lindberg, P Askelöf, B Hederstedt.   

Abstract

Antibody responses in human sera against Bordetella pertussis during natural infection were investigated by a microplate enzyme-linked immunosorbent assay (ELISA) with a purified fimbrial haemagglutinin preparation as antigen. Significant rises of specific IgG, IgM and IgA were demonstrated in paired sera. A secondary type of antibody response was found in most children and adults. In children, the type of response correlated with previous vaccination status; there was a primary response in unvaccinated children. A survey of antibodies in the general population showed low IgG titres in a small proportion of sera from the youngest healthy children. The titres and the number of individuals with measureable antibodies increased with age. In a limited study of the effect of vaccination, significant rises of titres were demonstrated after vaccination. The ELISA test was specific for antibodies against B. pertussis except that the test also seemed to measure antibody to B. parapertussis. A comparison between ELISA and the complement-fixation test showed a good correlation between the tests only in sera from children 1-12 years old.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292429     DOI: 10.1099/00222615-15-1-85

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  17 in total

1.  Prevalence of pertussis IgG antibodies in children in Palermo, Italy.

Authors:  T Stroffolini; A Giammanco; L De Crescenzo; F Lupo; V Nicosia; G Torres; A R Valenza; A Cascio; S Taormina; L Nisticò
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

2.  Evaluation of serologic assays for diagnosis of whooping cough.

Authors:  G Granström; B Wretlind; C R Salenstedt; M Granström
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

Review 3.  Pertussis: the disease and new diagnostic methods.

Authors:  R L Friedman
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

4.  Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis.

Authors:  S A Halperin; R Bortolussi; A J Wort
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

5.  Serum antibody response to filamentous hemagglutinin in patients with clinical pertussis measured by an enzyme-linked immunosorbent assay.

Authors:  G Zackrisson; F Arminjon; I Krantz; T Lagergård; N Sigurs; J Taranger; B Trollfors
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

6.  Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assay.

Authors:  G Zackrisson; I Krantz; T Lagergård; P Larsson; R Sekura; N Sigurs; J Taranger; B Trollfors
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

7.  Acellular pertussis vaccine in adults: adverse reactions and immune response.

Authors:  M Granström; M Thorén; M Blennow; M Tiru; Y Sato
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

8.  Distribution of immunity to pertussis in the population of England and Wales.

Authors:  P E Fine; J A Clarkson
Journal:  J Hyg (Lond)       Date:  1984-02

9.  Mixed outbreak of Bordetella pertussis and Bordetella parapertussis infection in Finland.

Authors:  J Mertsola
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

10.  Serum antibodies to the components of diphtheria-tetanus-pertussis vaccine in Polish children related to vaccination status.

Authors:  E Torbicka; T Lagergård; B Trollfors
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.